Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380

Neuropharmacology

Volumn 47, Issue 6, 2004, Pages 848-859

  Mogg, Adrian J ^a   Jones, Francis A ^a   Pullar, Ian A ^a   Sharples, Christopher G V ^b   Wonnacott, Susan ^b  

^a ELI LILLY AND COMPANY   (United States)

^b University of Bath   (United Kingdom)

Author keywords

Conotoxin MII; ACh release; Dopamine release; Neuronal nicotinic acetylcholine receptors; Noradrenaline release; Striatal synaptosomes

Indexed keywords

5 IODO 3 (2 AZETIDINYLMETHOXY)PYRIDINE; EPIBATIDINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NORADRENALIN; RECEPTOR SUBTYPE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ACTIVITY; DRUG BINDING; DRUG POTENCY; DRUG RESPONSE; INTERPEDUNCULAR NUCLEUS; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX; SYNAPTOSOME;

ACETYLCHOLINE; ANIMALS; AZETIDINES; BINDING, COMPETITIVE; CALCIUM; CELL LINE; DOPAMINE; FIBROBLASTS; FLUOROMETRY; INDICATORS AND REAGENTS; MICE; NEOSTRIATUM; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NOREPINEPHRINE; PYRIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RECEPTORS, PRESYNAPTIC; SYNAPTOSOMES;

EID: 7444246796     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.06.013     Document Type: Article

References (45)

1. Abreo M.A., Lin N.H., Garvey D.S., Gunn D.E., Hettinger A.M., Wasicak J.T., Pavlik P.A., Martin Y.C., Donnelly-Roberts D.L., Anderson D.J., Sullivan J.P., Williams M., Arneric S.P., Holladay M.W. Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. Journal of Medicinal Chemistry. 39:1996;817-825
2. 3H]- norepinephrine from rat brain slices using a new 96-well format assay. Neuropharmacology. 39:2000;2663-2672
3. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., McIntosh J.M. A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors. Journal of Biological Chemistry. 271:1996;7522-7528
4. Champtiaux N., Han Z.Y., Bessis A., Rossi F.M., Zoli M., Marubio L., McIntosh J.M., Changeux J.P. Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. Journal of Neuroscience. 22:2002;1208-1217
5. Champtiaux N., Gotti C., Cordero-Erausquin M., David D.J., Przybylski C., Lena C., Clementi F., Moretti M., Rossi F.M., Le Novere N., McIntosh J.M., Gardier A.M., Changeux J.P. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. Journal of Neuroscience. 23:2003;7820-7829
6. 50) of an enzymatic reaction. Biochemical Pharmacology. 22:1973;3099-3108
7. 3H]-dopamine release. British Journal of Pharmacology. 117:1996;595-606
8. Cui C., Booker T.K., Allen R.S., Grady S.R., Whiteaker P., Marks M.J., Salminen O., Tritto T., Butt C.M., Allen W.R., Stitzel J.A., McIntosh J.M., Boulter J., Collins A.C., Heinemann S.F. The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. Journal of Neuroscience. 23:2003;11045-11053
9. 2+ stores. Journal of Neurochemistry. 81:2002;606-614
10. 3H] methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology. 38:1999;679-690
11. Dowell C., Olivera B.M., Garrett J.E., Staheli S.T., Watkins M., Kuryatov A., Yoshikami D., Lindstrom J.M., McIntosh J.M. Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors. Journal of Neuroscience. 23:2003;8445-8452
12. Grady S.R., Meinerz N.M., Cao J., Reynolds A.M., Picciotto M.R., Changeux J.P., McIntosh J.M., Marks M.J., Collins A.C. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. Journal of Neurochemistry. 76:2001;258-268
13. Harvey S.C., Maddox F.N., Luetje C.W. Multiple determinants of dihydro-beta-erythroidine sensitivity on rat neuronal nicotinic receptor alpha subunits. Journal of Neurochemistry. 67:1996;1953-1959
14. Harvey S.C., McIntosh J.M., Cartier G.E., Maddox F.N., Luetje C.W. Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors. Molecular Pharmacology. 51:1997;336-342
15. Hogg R.C., Raggenbass M., Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Reviews of Physiology Biochemistry and Pharmacology. 147:2003;1-46
16. 3H]dopamine release from rat striatal synaptosomes and slices. Journal of Neurochemistry. 70:1998;1069-1076
17. Kulak J.M., McIntosh J.M., Yoshikami D., Olivera B.M. Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels. Journal of Neurochemistry. 77:2001;1581-1589
18. * subtypes. Journal of Neurochemistry. 81:2002;403-406
19. Lena C., de Kerchove D.E., Cordero-Erausquin M., Le Novere N., del Mar A., Changeux J.P. Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. Proceedings of the National Academy of Sciences USA. 96:1999;12126-12131
20. Le Novere N., Zoli M., Changeux J.-P. Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. European Journal of Neuroscience. 8:1996;2428-2439
21. 3H]norepinephrine from developing and adult rat hippocampus: direct and indirect mechanisms. Neuropharmacology. 42:2002;653-661
22. Lewis T.M., Harkness P.C., Sivilotti L.G., Colquhoun D., Millar N.S. The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type. Journal of Physiology (London). 505:(pt. 2):1997;299-306
23. Lindstrom J., Anand R., Gerzanich V., Peng X., Wang F., Wells G. Structure and function of nicotinic acetylcholine receptors. Progress in Brain Research. 109:1996;125-137
24. 3H]nicotine binding to putative high affinity receptor sites in rat brain. Molecular Pharmacology. 31:1987;392-400
25. Lukas R.J., Norman S.A., Lucero L. Characterization of nicotinic acetylcholine receptors expressed in cells of the SH-SY5Y human neuroblastoma clonal cell line. Molecular and Cellular Neuroscience. 4:1993;1-12
26. Luo S., Kulak J.M., Cartier G.E., Jacobsen R.B., Yoshikami D., Olivera B.M., McIntosh J.M. Alpha-conotoxin AuIB selectively blocks alpha3beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. Journal of Neuroscience. 18:1998;8571-8579
27. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., Collins A.C. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. Journal of Neuroscience. 12:1992;2765-2784
28. Marks M.J., Pauly J.P., Grun E.U., Collins A.C. ST/b and DBA/2 mice differ in brain α-bungarotoxin binding and α7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis. Molecular Brain Research. 39:1996;207-222
29. Mogg A.J., Whiteaker P., McIntosh J.M., Marks M., Collins A.C., Wonnacott S. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. Journal of Pharmacology and Experimental Therapeutics. 302:2002;197-204
30. Mogg, A.J., Jones, F.A., Pullar, I.A., Sharples, C.G.V., Wonnacott, S., 2003. Functional studies with the novel nicotinic acetylcholine receptor (nAChR) agonist 5-iodo-A-85380. Program No. 158.10. 2003 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC (online).
31. Mukhin A.G., Gundisch D., Horti A.G., Koren A.O., Tamagnan G., Kimes A.S., Chambers J., Vaupel D.B., King S.L., Picciotto M.R., Innis R.B., London E.D. 5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Molecular Pharmacology. 57:2000;642-649
32. 11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacology (Berlin). 115:1994;31-36
33. Peng X., Gerzanich V., Anand R., Wang F., Lindstrom J. Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Molecular Pharmacology. 51:1997;776-784
34. * and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. British Journal of Pharmacology. 133:2001;1286-1295
35. Ridley, D.L., Pakkanen, J., Wonnacott, S., 2002. Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cells. British Journal of Pharmacology 135, 1051-1059.
36. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085
37. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annual Review of Neuroscience. 16:1993;403-443
38. * subtype in the modulation of dopamine release from rat striatal synaptosomes. Journal of Neuroscience. 20:2000;2783-2791
39. Sharples C.G., Karig G., Simpson G.L., Spencer J.A., Wright E., Millar N.S., Wonnacott S., Gallagher T. Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165. Journal of Medicinal Chemistry. 45:2002;3235-3245
40. Sullivan J.P., Donnelly-Roberts D., Briggs C.A., Anderson D.J., Gopalakrishnan M., Piattoni-Kaplan M., Campbell J.E., McKenna D.G., Molinari E., Hettinger A.M., Garvey D.S., Wasicak J.T., Holladay M.W., Williams M., Arneric S.P. A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand. Neuropharmacology. 35:1996;725-734
41. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., Lindstrom J. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. Journal of Biological Chemistry. 271:1996;17656-17665
42. (125)I]-epibatidine. British Journal of Pharmacology. 131:2000;729-739
43. Whiteaker P., Peterson C.G., Xu W., McIntosh J.M., Paylor R., Beaudet A.L., Collins A.C., Marks M.J. Involvement of the alpha3 subunit in central nicotinic binding populations. Journal of Neuroscience. 22:2002;2522-2529
44. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends in Neuroscience. 20:1997;92-98
45. Zoli M., Moretti M., Zanardi A., McIntosh J.M., Clementi F., Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. Journal of Neuroscience. 22:2002;8785-8789